Linkage Global Inc

Aktienanalyse zu Linkage Global Inc (UZX)

$1.010

0.000 (0.00%)Zum Schluss

Loading chart…
Hoch
1.020
Eröffnung
1.000
Volumengewichteter Durchschnittskurs
1.01
Volumen
17.12K
Marktkap.
—
Tief
1.000
Umsatz
17.29K
EV/EBITDA, TTM
0.00

Linkage Global Inc is a Japan-based company mainly engaged in the provision of cross-border e-commerce integrated services. The Company is engaged in the development of a comprehensive service system comprised of two lines of business complementary to each other, including cross-border sales and integrated e-commerce services. Cross-border sales business is engaged in the import and export sales of products are sourced from Japanese and Chinese manufacturers and brands, and private label smart products. The main products include pharmaceuticals, cosmetics, detergents, sanitary products, daily necessities, foodstuffs, alcoholic beverages, miscellaneous goods, household electrical appliances and others. Integrated e-commerce business is engaged in the provision of digital marketing services to the merchants through connecting the merchants with social media platforms.

www.linkagecc.com

KI-Analyse of Linkage Global Inc (UZX)

Halten

Linkage Global Inc (UZX) is currently not a strong buy due to its significant price decline of 89.34% year-to-date and a low RSI of 37.774, indicating potential oversold conditions. The stock is trading at $1.01, which is near its 52-week low of $0.75, and it has received a Nasdaq warning for trading below $1 for over 30 days, posing a risk of delisting. While the recent approval of an $8 million share buyback program could provide some support, the company's net loss of $1.67 million in the first half of 2025 and a 25.1% decline in revenue raise concerns about its financial health. Therefore, it is advisable to hold off on buying until there are clearer signs of recovery and compliance with Nasdaq requirements.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Linkage Global Inc (UZX) beträgt 0.00, verglichen mit dem 5-Jahres-Durchschnitt von .

Erwartetes KGV

5J-Durchschnitt P/E
Aktuelles P/E
0.00

Erwartetes EV/EBITDA

5J-Durchschnitt EV/EBITDA
Aktuelles EV/EBITDA
0.00

Erwartetes KUV

5J-Durchschnitt P/S
Aktuelles P/S
0.00

Event-Zeitleiste

2026-09-29 (ET)

17:00:00

Linkage Global Terminates $20M Investment Agreement with Capital Finance

2026-09-18 (ET)

20:00:00

Linkage Global Inc Trading Halted, News Pending

2026-09-17 (ET)

07:00:00

Linkage Global Shareholders Approve 23-for-1 Share Consolidation

2026-09-14 (ET)

08:30:00

Linkage Global Signs Strategic Investment Agreement with Capital Finance for $20M

2026-08-11 (ET)

06:30:00

Linkage Global Explores Opportunities in Hospitality Industry

News

UZX FAQ – beantwortet von Alphio AI

Linkage Global Inc is a Japan-based company mainly engaged in the provision of cross-border e-commerce integrated services. The Company is engaged in the development of a comprehensive service system comprised of two lines of business complementary to each other, including cross-border sales and integrated e-commerce services. Cross-border sales business is engaged in the import and export sales of products are sourced from Japanese and Chinese manufacturers and brands, and private label smart products. The main products include pharmaceuticals, cosmetics, detergents, sanitary products, daily necessities, foodstuffs, alcoholic beverages, miscellaneous goods, household electrical appliances and others. Integrated e-commerce business is engaged in the provision of digital marketing services to the merchants through connecting the merchants with social media platforms. It operates in the Consumer Cyclicals sector.

Linkage Global Inc (UZX) is currently not a strong buy due to its significant price decline of 89.34% year-to-date and a low RSI of 37.774, indicating potential oversold conditions. The stock is trading at $1.01, which is near its 52-week low of $0.75, and it has received a Nasdaq warning for trading below $1 for over 30 days, posing a risk of delisting. While the recent approval of an $8 million share buyback program could provide some support, the company's net loss of $1.67 million in the first half of 2025 and a 25.1% decline in revenue raise concerns about its financial health. Therefore, it is advisable to hold off on buying until there are clearer signs of recovery and compliance with Nasdaq requirements.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Ähnliche Artikel

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln